RGNT (Regentis Biomaterials) Total Assets: $7.62 Mil (As of Dec. 2025)


RGNT Regentis Biomaterials Ltd RGNT
14 GF Score
Price $3.90
! 2 Warning Signs
View Full Analysis

What is Regentis Biomaterials Total Assets?

Regentis Biomaterials RGNT -6.02% 14 Total Assets is $7.62 Mil as of Dec. 2025. GuruFocus rates RGNT with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Regentis Biomaterials's Total Assets for the quarter that ended in Dec. 2025 was $7.62 Mil.

During the past 12 months, Regentis Biomaterials's average Total Assets Growth Rate was -5.10% per year. During the past 3 years, the average Total Assets Growth Rate was -20.50% per year. During the past 5 years, the average Total Assets Growth Rate was 45.30% per year.

During the past 6 years, Regentis Biomaterials's highest 3-Year average Total Assets Growth Rate was 28.90%. The lowest was -20.50%. And the median was -12.00%.

Total Assets is connected with ROA %. Regentis Biomaterials's annualized ROA % for the quarter that ended in Dec. 2025 was -515.01%. Total Assets is also linked to Revenue through Asset Turnover. Regentis Biomaterials's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Regentis Biomaterials  (AMEX:RGNT) Total Assets Explanation

Total Assets is connected with ROA %.

Regentis Biomaterials's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-20.84/( (0.475+7.618)/ 2 )
=-20.84/4.0465
=-515.01 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Regentis Biomaterials's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (0.475+7.618)/ 2 )
=0/4.0465
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Regentis Biomaterials Total Assets Related Terms

Regentis Biomaterials Total Assets Historical Data

* Premium members only.

The historical data trend for Regentis Biomaterials's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regentis Biomaterials Total Assets Chart

Regentis Biomaterials Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 3.12 1.72 0.36 0.48 7.62

Regentis Biomaterials Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.36 0.20 0.48 0.48 7.62
RGNT
14GF Score
Regentis Biomaterials Ltd RGNT
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regentis Biomaterials Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Regentis Biomaterials's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=4.744+2.874
=7.62

Regentis Biomaterials's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=4.744+2.874
=7.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $7.62 Mil mean?
Regentis Biomaterials (RGNT) has a Total Assets of $7.62 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Regentis Biomaterials and its competitors.
Is Regentis Biomaterials' Total Assets too high?
Regentis Biomaterials' current Total Assets is $7.62 Mil. Overall, Regentis Biomaterials has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Regentis Biomaterials' Total Assets compare to MHUAF and LUCY?
Regentis Biomaterials' Total Assets of $7.62 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Regentis Biomaterials and its competitors. Regentis Biomaterials's current Total Assets is $7.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regentis Biomaterials stock overvalued right now?
Regentis Biomaterials (RGNT) has a current Total Assets of $7.62 Mil. The current Total Assets is $7.62 Mil. Regentis Biomaterials' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Regentis Biomaterials (RGNT), the current Total Assets is $7.62 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regentis Biomaterials Business Description

Address 60, Medinat Hyahudim, Entrance C, Herzlia Pituach, ISR, 4676652
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
14GF Score

Get the complete analysis for RGNT

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.90
Price